Page last updated: 2024-10-25

cimetidine and Chronic Kidney Disease-Mineral and Bone Disorder

cimetidine has been researched along with Chronic Kidney Disease-Mineral and Bone Disorder in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Chronic Kidney Disease-Mineral and Bone Disorder: Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schaefer, K1

Other Studies

1 other study available for cimetidine and Chronic Kidney Disease-Mineral and Bone Disorder

ArticleYear
[Therapy of uremic osteopathy].
    Deutsche medizinische Wochenschrift (1946), 1980, Nov-28, Volume: 105, Issue:48

    Topics: Aluminum Hydroxide; Aluminum Oxide; Calcitonin; Chronic Kidney Disease-Mineral and Bone Disorder; Ci

1980